Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Irregularities in genetic variation and mutation rates with environmental stresses.

Ferenci T.

Environ Microbiol. 2019 Oct 10. doi: 10.1111/1462-2920.14822. [Epub ahead of print]

PMID:
31600848
2.

Corrigendum to 'Trends in Major Lower Limb Amputations Related to Peripheral Arterial Disease in Hungary. A Nationwide Study (2004-2012).'[European Journal of Vascular & Endovascular Surgery 50/1 (2015) 78-85].

Kolossváry E, Ferenci T, Kováts T, Kovács L, Járai Z, Menyhei G, Farkas K.

Eur J Vasc Endovasc Surg. 2019 Sep 11. pii: S1078-5884(19)31380-2. doi: 10.1016/j.ejvs.2019.07.025. [Epub ahead of print] No abstract available.

PMID:
31521487
3.

Does The Type of Ossicular Chain Lesion Affect Outcomes in Chronic Suppurative Otitis Media Without Cholesteatoma?

Horvath T, Lukacs D, Horvath B, Ferenci T, Liktor B.

J Int Adv Otol. 2019 Apr;15(1):28-33. doi: 10.5152/iao.2019.5554.

4.

[One-year persistence of patients already treated with oral anticoagulants for atrial fibrillation].

Simonyi G, Ferenci T, Finta E, Gasparics R, Medvegy M.

Orv Hetil. 2019 Mar;160(13):509-515. doi: 10.1556/650.2019.31347. Hungarian.

PMID:
30907102
5.

[One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].

Simonyi G, Ferenci T, Finta E, Igaz I, Balogh S, Gasparics R, Medvegy M.

Orv Hetil. 2019 Mar;160(9):343-348. doi: 10.1556/650.2019.31355. Hungarian.

PMID:
30798621
6.

Can Google Trends data improve forecasting of Lyme disease incidence?

Kapitány-Fövény M, Ferenci T, Sulyok Z, Kegele J, Richter H, Vályi-Nagy I, Sulyok M.

Zoonoses Public Health. 2019 Feb;66(1):101-107. doi: 10.1111/zph.12539. Epub 2018 Nov 16.

PMID:
30447056
7.

Does Gender Have Prognostic Value Among Patients with Myocardial Infarction? Analysis of the Data from the Hungarian Myocardial Infarction Registry.

Jánosi A, Ferenci T, Ofner P, Lupkovics G, Becker D, Faluközy J, Polgár P, Kőszegi Z, Horváth I, Jambrik Z, Szentes V, Merkely B, Dézsi CA.

J Womens Health (Larchmt). 2018 Oct 10. doi: 10.1089/jwh.2017.6763. [Epub ahead of print]

PMID:
30307791
8.

Escherichia coli mutation rates and spectra with combinations of environmental limitations.

Maharjan RP, Ferenci T.

Microbiology. 2018 Dec;164(12):1491-1502. doi: 10.1099/mic.0.000727. Epub 2018 Oct 5.

PMID:
30300121
9.

The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders.

Fábián A, Rutka M, Ferenci T, Bor R, Bálint A, Farkas K, Milassin Á, Szántó K, Lénárt Z, Nagy F, Szepes Z, Molnár T.

Gastroenterol Res Pract. 2018 Apr 3;2018:9137805. doi: 10.1155/2018/9137805. eCollection 2018.

10.

The impact of growth rate and environmental factors on mutation rates and spectra in Escherichia coli.

Maharjan RP, Ferenci T.

Environ Microbiol Rep. 2018 Dec;10(6):626-633. doi: 10.1111/1758-2229.12661. Epub 2018 Sep 26.

PMID:
29797781
11.

[The significance of ECG recorded at hospitalization in determining the prognosis of patients treated with myocardial infarction].

Jánosi A, Ofner P, Tomcsányi J, Müller G, Hável R, Soczó AR, Váradi T, Ferenci T.

Orv Hetil. 2018 Apr;159(17):677-681. doi: 10.1556/650.2018.31013. Hungarian.

PMID:
29681178
12.

[Effect of smoking on survival after myocardial infarction - smoker's paradox in Hungary?]

El-Meouch NM, Ferenci T, Jánosi A.

Orv Hetil. 2018 Apr;159(14):557-565. doi: 10.1556/650.2018.31028. Hungarian.

PMID:
29611752
13.

[One year adherence of ramipril versus ramipril/amlodipine fixed dose combination therapy in hypertension].

Simonyi G, Ferenci T.

Orv Hetil. 2017 Oct;158(42):1669-1673. doi: 10.1556/650.2017.30882. Hungarian.

PMID:
29037057
14.

[One year persistence of free and fixed dose combinations of perindopril/amlodipine].

Simonyi G, Ferenci T, Medvegy M, Gasparics R, Finta E.

Orv Hetil. 2017 Sep;158(36):1421-1425. doi: 10.1556/650.2017.30851. Hungarian.

PMID:
28868908
15.

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center.

Farkas K, Rutka M, Ferenci T, Nagy F, Bálint A, Bor R, Milassin Á, Fábián A, Szántó K, Végh Z, Kürti Z, Lakatos PL, Szepes Z, Molnár T.

Expert Opin Biol Ther. 2017 Nov;17(11):1325-1332. doi: 10.1080/14712598.2017.1363885. Epub 2017 Aug 18.

PMID:
28819991
16.

The fitness costs and benefits of antibiotic resistance in drug-free microenvironments encountered in the human body.

Maharjan R, Ferenci T.

Environ Microbiol Rep. 2017 Oct;9(5):635-641. doi: 10.1111/1758-2229.12564. Epub 2017 Jul 13.

PMID:
28677342
17.

[Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].

Jánosi A, Ofner P, Kiss Z, Kiss L, Kiss RG, Dinnyés J, Járai Z, Nagy G, Veress G, Ferenci T.

Orv Hetil. 2017 Jul;158(27):1051-1057. doi: 10.1556/650.2017.30795. Hungarian.

PMID:
28670984
18.

A shifting mutational landscape in 6 nutritional states: Stress-induced mutagenesis as a series of distinct stress input-mutation output relationships.

Maharjan RP, Ferenci T.

PLoS Biol. 2017 Jun 8;15(6):e2001477. doi: 10.1371/journal.pbio.2001477. eCollection 2017 Jun.

19.

The issue of plasma asymmetric dimethylarginine reference range - A systematic review and meta-analysis.

Németh B, Ajtay Z, Hejjel L, Ferenci T, Ábrám Z, Murányi E, Kiss I.

PLoS One. 2017 May 11;12(5):e0177493. doi: 10.1371/journal.pone.0177493. eCollection 2017. Review.

20.

Variable selection should be blinded to the outcome.

Ferenci T.

Int J Epidemiol. 2017 Jun 1;46(3):1077-1079. doi: 10.1093/ije/dyx048. No abstract available.

PMID:
28402483
21.

[A családorvosok alvási apnoéval kapcsolatos ismeretei és attitűdjei. Megvalósul-e az OSAS szűrése a járművezetők egészségi alkalmasságának vizsgálata során?]

Csatlós D, Ferenci T, Kalabay L, László A, Hargittay C, Márkus B, Szakács Z, Torzsa P.

Ideggyogy Sz. 2017 Mar 30;70(3-4):105-113. doi: 10.18071/isz.70.0105. Hungarian.

PMID:
29870615
22.

Natural Escherichia coli isolates rapidly acquire genetic changes upon laboratory domestication.

Liu B, Eydallin G, Maharjan RP, Feng L, Wang L, Ferenci T.

Microbiology. 2017 Jan;163(1):22-30. doi: 10.1099/mic.0.000405.

PMID:
28198347
23.

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals.

Sulyok M, Ferenci T, Makara M, Horváth G, Szlávik J, Rupnik Z, Kormos L, Gerlei Z, Sulyok Z, Vályi-Nagy I.

PeerJ. 2017 Jan 11;5:e2867. doi: 10.7717/peerj.2867. eCollection 2017.

24.

The fitness costs and trade-off shapes associated with the exclusion of nine antibiotics by OmpF porin channels.

Phan K, Ferenci T.

ISME J. 2017 Jun;11(6):1472-1482. doi: 10.1038/ismej.2016.202. Epub 2017 Jan 10.

25.

Five-year outcome of consecutive unprotected left main percutaneous coronary interventions.

Piroth Z, Ferenci T, Fontos G, Szonyi T, Nemeth J, Szoke S, Chaurasia AK, Andreka P.

Acta Cardiol. 2016;71(6):654-662. doi: 10.2143/AC.71.6.3178183. No abstract available.

PMID:
27920452
26.

Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.

Kocsis A, Takács T, Jeney C, Schaff Z, Koiss R, Járay B, Sobel G, Pap K, Székely I, Ferenci T, Lai HC, Nyíri M, Benczik M.

Int J Cancer. 2017 Mar 1;140(5):1119-1133. doi: 10.1002/ijc.30534.

27.

[Prognostic significance of the culprit vessel in patients with ST-elevation myocardial infarction treated with primary coronary intervention].

Jánosi A, Ofner P, Simkovits D, Ferenci T.

Orv Hetil. 2016 Aug;157(32):1282-8. doi: 10.1556/650.2016.30506. Hungarian.

PMID:
27499287
28.

Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence.

Simonyi G, Ferenci T, Alföldi S, Farsang C.

J Int Med Res. 2016 Oct;44(5):1087-1091. doi: 10.1177/0300060516645004. Epub 2016 Jul 20.

29.

[One year persistence of metformin monotherapy versus metformin/sitagliptin fixed dose combination].

Simonyi G, Ferenci T.

Orv Hetil. 2016 Apr 17;157(16):618-22. doi: 10.1556/650.2016.30423. Hungarian.

PMID:
27063429
30.

[One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].

Simonyi G, Ferenci T.

Orv Hetil. 2016 Mar 13;157(11):425-9. doi: 10.1556/650.2016.30401. Hungarian.

PMID:
26947091
31.

[Bexsero, a novel vaccine against meningococcus].

Lakos A, Torzsa P, Ferenci T.

Orv Hetil. 2016 Feb 14;157(7):242-6. doi: 10.1556/650.2016.30333. Review. Hungarian.

PMID:
26853725
32.

Effective case/infection ratio of poliomyelitis in vaccinated populations.

Bencskó G, Ferenci T.

Epidemiol Infect. 2016 Jul;144(9):1933-42. doi: 10.1017/S0950268816000078. Epub 2016 Feb 2.

PMID:
26830060
33.

[Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].

Simonyi G, Ferenci T.

Orv Hetil. 2016 Jan 3;157(1):30-4. doi: 10.1556/650.2016.30344. Hungarian.

PMID:
26708684
34.

Metastable coexistence of multiple genotypes in a constant environment with a single resource through fixed settings of a multiplication-survival trade-off.

Maharjan R, Ferenci T.

Res Microbiol. 2016 Apr;167(3):240-6. doi: 10.1016/j.resmic.2015.12.001. Epub 2015 Dec 17.

PMID:
26706690
35.

Trade-off Mechanisms Shaping the Diversity of Bacteria.

Ferenci T.

Trends Microbiol. 2016 Mar;24(3):209-223. doi: 10.1016/j.tim.2015.11.009. Epub 2015 Dec 17. Review.

PMID:
26705697
36.

Absolute risk reduction may depend on the duration of the follow-up.

Ferenci T.

Expert Rev Clin Pharmacol. 2017 Dec;10(12):1409-1410. doi: 10.1586/17512433.2015.1102008. Epub 2015 Nov 2.

PMID:
26524403
37.

How Porin Heterogeneity and Trade-Offs Affect the Antibiotic Susceptibility of Gram-Negative Bacteria.

Ferenci T, Phan K.

Genes (Basel). 2015 Oct 21;6(4):1113-24. doi: 10.3390/genes6041113.

38.

Quantitative impact of direct, personal feedback on hand hygiene technique.

Lehotsky Á, Szilágyi L, Ferenci T, Kovács L, Pethes R, Wéber G, Haidegger T.

J Hosp Infect. 2015 Sep;91(1):81-4. doi: 10.1016/j.jhin.2015.05.010. Epub 2015 Jun 16.

PMID:
26136103
39.

Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study.

Sulyok M, Makara M, Rupnik Z, Ferenci T, Újhelyi E, Kormos L, Gerlei Z, Szlávik J, Horváth G, Vályi-Nagy I.

Eur J Gastroenterol Hepatol. 2015 Jun;27(6):679-85. doi: 10.1097/MEG.0000000000000339.

PMID:
25923943
40.

Trends in Major Lower Limb Amputation Related to Peripheral Arterial Disease in Hungary: A Nationwide Study (2004-2012).

Kolossváry E, Ferenci T, Kováts T, Kovács L, Járai Z, Menyhei G, Farkas K.

Eur J Vasc Endovasc Surg. 2015 Jul;50(1):78-85. doi: 10.1016/j.ejvs.2015.02.019. Epub 2015 Apr 2. Erratum in: Eur J Vasc Endovasc Surg. 2019 Sep 11;:.

41.

The interrelationship of HbA1c and real-time continuous glucose monitoring in children with type 1 diabetes.

Ferenci T, Körner A, Kovács L.

Diabetes Res Clin Pract. 2015 Apr;108(1):38-44. doi: 10.1016/j.diabres.2015.01.019. Epub 2015 Jan 21.

PMID:
25666106
42.

[Low persistence of simvastatin and ezetimibe fixed combination in the lipid lowering therapy].

Simonyi G, Ferenci T.

Orv Hetil. 2015 Jan 25;156(4):141-5. doi: 10.1556/OH.2015.30085. Hungarian.

PMID:
25597318
43.

Simple phenotypic sweeps hide complex genetic changes in populations.

Maharjan RP, Liu B, Feng L, Ferenci T, Wang L.

Genome Biol Evol. 2015 Jan 13;7(2):531-44. doi: 10.1093/gbe/evv004.

44.

[Medication adherence with the fixed combination of ramipril and amlodipine].

Simonyi G, Ferenci T.

Orv Hetil. 2014 Nov 23;155(47):1882-8. doi: 10.1556/OH.2014.30037. Hungarian.

PMID:
25403283
45.

Mutational signatures indicative of environmental stress in bacteria.

Maharjan R, Ferenci T.

Mol Biol Evol. 2015 Feb;32(2):380-91. doi: 10.1093/molbev/msu306. Epub 2014 Nov 11.

PMID:
25389207
47.

Stress-induced mutation rates show a sigmoidal and saturable increase due to the RpoS sigma factor in Escherichia coli.

Maharjan R, Ferenci T.

Genetics. 2014 Nov;198(3):1231-5. doi: 10.1534/genetics.114.170258. Epub 2014 Sep 10.

48.

A metabolic trade-off between phosphate and glucose utilization in Escherichia coli.

Behrends V, Maharjan RP, Ryall B, Feng L, Liu B, Wang L, Bundy JG, Ferenci T.

Mol Biosyst. 2014 Nov;10(11):2820-2. doi: 10.1039/c4mb00313f.

PMID:
25141987
49.

Epistatic interactions determine the mutational pathways and coexistence of lineages in clonal Escherichia coli populations.

Maharjan RP, Ferenci T.

Evolution. 2013 Sep;67(9):2762-8. doi: 10.1111/evo.12137. Epub 2013 May 22.

PMID:
24033182
50.

The form of a trade-off determines the response to competition.

Maharjan R, Nilsson S, Sung J, Haynes K, Beardmore RE, Hurst LD, Ferenci T, Gudelj I.

Ecol Lett. 2013 Oct;16(10):1267-76. doi: 10.1111/ele.12159. Epub 2013 Jul 31.

PMID:
23902419

Supplemental Content

Loading ...
Support Center